Table 2.
Group A (n = 22) | Group-B (n = 14) | P | |
Early response | |||
Virological (%) | 82.4 | 0 | < 0.001 |
End-of-treatment response | |||
Virological (%) | 82.4 | 0 | < 0.001 |
Sustained response | |||
Virological (%) | 64.7 | 0 | < 0.001 |
Group A (n = 22) | Group-B (n = 14) | P | |
Early response | |||
Virological (%) | 82.4 | 0 | < 0.001 |
End-of-treatment response | |||
Virological (%) | 82.4 | 0 | < 0.001 |
Sustained response | |||
Virological (%) | 64.7 | 0 | < 0.001 |